Form 4: TSS Inc. CFO Sells 15,000 Shares Under 10b5-1 Plan

TSS Inc.'s Chief Financial Officer, Daniel M. Chism, sold 15,000 shares of common stock at a weighted average price of $16.17 per share as part of a pre-planned trading arrangement.

Summary

• Daniel M. Chism, Chief Financial Officer of TSS, Inc., disposed of 15,000 shares of the company's common stock.
• The transaction occurred on September 10, 2025.
• The shares were sold at a weighted average price of $16.17 per share, with individual transactions ranging from $16.15 to $16.19.
• Following this transaction, Mr. Chism beneficially owns 296,219 shares of TSS, Inc. common stock.
• The sale was executed pursuant to a Rule 10b5-1(c) pre-planned trading arrangement.

Sentiment

Score: 5

Explanation: The filing reports a pre-planned sale of shares by the CFO. While insider selling can sometimes be viewed negatively, the 10b5-1 plan mitigates concerns about opportunistic timing. It's a routine transaction for an executive and does not provide new fundamental information about the company's operations.

Positives

• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled sale rather than an immediate reaction to new, undisclosed information.

Negatives

• Chief Financial Officer Daniel M. Chism disposed of 15,000 shares of company common stock.

Risks

• Potential for negative market perception due to an insider selling shares, despite the transaction being pre-planned under a Rule 10b5-1(c) plan.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Sale of 15,000 shares of common stock by Chief Financial Officer Daniel M. Chism to the open market at a weighted average price of $16.17 per share.

Stakeholder Impact

• Shareholders may interpret the CFO's sale as a signal, though the Rule 10b5-1 plan suggests it is not based on new, undisclosed negative information, potentially mitigating significant concern.

Key Dates

Recommendation

This Form 4 reports a routine, pre-planned insider sale by the CFO. It does not provide new fundamental information about the company's operations, financial health, or strategic direction that would warrant a change in investment recommendation. Investors should consider this transaction as part of a broader assessment of the company and its stock, but it does not independently suggest a 'buy' or 'sell' action.

Keywords

TSS Inc., TSSI, insider trading, Form 4, CFO, stock sale, Daniel M. Chism, Rule 10b5-1